Bragar Eagel & Squire, P.C. is investigating Pathward Financial following the company's fiscal Q3 2026 results, which missed expectations due to a surge in nonperforming loans to $275.1 million, nearly triple analyst estimates. This included problematic loans to renewable-energy projects, prompting Pathward to lower its full-year earnings guidance. The stock fell 6.26% after the announcement. The law firm is encouraging affected investors to contact them to discuss potential claims related to securities law violations or other unlawful practices.
Halper Sadeh LLC is investigating whether the sales and mergers involving Utz Brands, BioLife Solutions, and Northrim BanCorp provide fair financial terms to their shareholders. The firm suspects insiders might gain benefits not available to ordinary...
Mesoblast announced $36 million in net revenue for Q4 and $115 million for the first full year following FDA approval of its Ryoncil therapy, used to treat steroid-refractory acute graft versus host disease (SR-aGvHD) in children. The company is expa...
Fortuna Mining Corp. has approved a $109 million expansion of its Séguéla Gold Mine in Côte d’Ivoire, increasing processing capacity by 30% from 1.75 to 2.3 million tonnes per annum and improving gold recovery to 94.5%. This expansion includes upgrad...
A class action lawsuit has been filed against Park Ha Biological Technology for allegedly being involved in a market manipulation and fraudulent promotion scheme using social media misinformation and impersonation of financial professionals. The comp...
The US Federal Communications Commission (FCC) has restricted imports of foreign-made humanoid robots citing cybersecurity risks, escalating tensions with China. China's commerce ministry condemned the move, calling it damaging to US-China trade rela...
